MedPath

Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy

Not Applicable
Recruiting
Conditions
Healthy
Registration Number
NCT07122739
Lead Sponsor
Trustees of Princeton University
Brief Summary

This study tests the efficacy of a new behavioral intervention with the goal of reducing spontaneous recovery of threat expectancy in healthy adults. This real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention delivers feedback based on a functional connection between the prefrontal cortex and the hippocampus.

Detailed Description

Exposure therapy remains the most effective evidence-based treatment for a variety of anxiety related disorders; however, fear often returns over time. Pavlovian conditioning and extinction serve as a laboratory model for threat learning and exposure therapy, respectively. Studies utilizing these tasks can help uncover why exposure therapy fails to prevent the return of fear in some individuals. Pilot data suggest that there are specific behavioral phenotypes that individuals exhibit during a test of spontaneous recovery following Pavlovian acquisition and extinction. Specifically, some participants exhibit high spontaneous recovery, despite previously extinguishing their responses. The investigators hypothesize that individuals that exhibit this behavioral phenotype are also individuals for whom exposure therapy would be ineffective. These distinct phenotypes are also associated with different forms of computational inference, as revealed by fitting latent-cause inference models to behavioral data. In the case of individuals that exhibit high spontaneous recovery, latent cause inference modeling suggests that these participants are reinstating a latent cause associated with initial threat learning, which was protected from updating by the formation of a new cause during extinction.

A separate line of work has focused on understanding the behavioral consequences and neural mechanisms of voluntary thought suppression, or inhibitory memory control. This is the process through which an individual can suppress a memory to reduce the influence that it has over future cognition and emotion. The neural mechanisms of retrieval inhibition are well known and involve top-down inhibition from the right dorsal-lateral prefrontal cortex (dlPFC) to the hippocampus.

Here, the investigators aim to test the hypothesis that memory control ability is related to latent cause inference during Pavlovian conditioning and extinction, and by extension is related to spontaneous recovery. The goal of this project is to causally test this hypothesis by using real-time fMRI to directly strengthen individuals' memory control ability. Real-time fMRI (rt-fMRI) neurofeedback is a powerful tool that allows participants to modulate their own neural activity based on external cues (akin to biofeedback). Here, the investigators will provide participants feedback designed to help them increase their memory control ability. Specifically, the investigators will give participants positive feedback whenever the investigators detect negative dlPFC-hippocampal functional connectivity, which is the putative neural signature of successful memory inhibition. A control group will also be included, which will involve the delivery of sham placebo neurofeedback. The investigators predict that, following rt-fMRI neurofeedback, participants who received active neurofeedback aimed at increasing memory control will exhibit lower spontaneous recovery in a Pavlovian conditioning task compared to the control group.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adults aged 18-50
  • No history of psychiatric disorders or neurological disorders affecting the central nervous system.
  • Are not currently taking psychoactive medication or drugs of abuse.
  • Must be eligible to enter an MRI (i.e., no permanent metal or medical implants)
  • Normal color vision
  • Right-handed
  • Full reading and writing English comprehension
  • Must exhibit spontaneous recovery behavior as determined by an experimenter in a prescreening experimental session
  • Must be able to provide informed consent
Exclusion Criteria
  • Pregnancy (female participants)
  • Outside of age range
  • History of psychiatric or neurological disease
  • Currently taking psychoactive medication or drugs of abuse
  • Color blindness
  • Primary left-handedness
  • Less than full reading and writing English comprehension
  • Do not exhibit spontaneous recovery behavior as determined by an experimenter in a prescreening experimental session
  • Refusing to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Spontaneous recovery behaviorBaseline and fourth fMRI session (out of four total fMRI sessions). At most 60 days will elapse between the start of data collection for a participant and their final fMRI session.

The investigators will assess neurofeedback related changes in behavioral threat expectancy ratings in a discriminatory Pavlovian conditioning task. Spontaneous recovery is taken as the difference in responding to the conditioned stimulus that was paired with an outcome (CS+) vs. the conditioned stimulus that was not paired with an outcome (CS-) during a test of extinction recall following acquisition and extinction learning.

Secondary Outcome Measures
NameTimeMethod
Neurofeedback learningSecond and third fMRI sessions (out of four total fMRI sessions). At most 60 days will elapse between the start of data collection for a participant and their final fMRI session.

The investigators will assess the overall trend in neurofeedback scores over the course of the intervention. If neurofeedback learning is successful, the investigators expect participants in the experimental group to increase the number of positive neurofeedback instances as the experiment progresses.

Trial Locations

Locations (1)

Princeton Neuroscience Institute

🇺🇸

Princeton, New Jersey, United States

Princeton Neuroscience Institute
🇺🇸Princeton, New Jersey, United States
Augustin C. Hennings, Ph.D.
Contact
gus.hennings@princeton.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.